Adani and Sirius form JV to digitally transform India's digital economy
Sirius JV will be owned 51% by Sirius and 49% by Adani
Sirius JV will be owned 51% by Sirius and 49% by Adani
The brands Aarne in Germany and Nalcrom in Canada and the Netherlands are being acquired
The transfer of the distribution rights will strengthen Sandoz's immunology and biosimilar portfolio
The CAPSUL solution enables optimal process performance for production of premier quality PCL grades at competitive rates
Orgovyx is the first and only oral GnRH receptor antagonist approved for advanced prostate cancer in Canada
Biocon will be responsible for obtaining regulatory approval for Liraglutide, and thereafter, for the manufacture and supply of the product in the Canadian market
WINLEVI works differently from any other topical acne treatment
The updated COVID-19 vaccine is tailored to the Omicron XBB.1.5 sublineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older
Propranolol LA is a generic equivalent of Inderal LA
The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x
Subscribe To Our Newsletter & Stay Updated